Last $3.31 USD
Change Today -0.08 / -2.36%
Volume 16.0K
LPDX On Other Exchanges
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

liposcience inc (LPDX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/15/13 - $6.92
52 Week Low
04/15/14 - $2.92
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LIPOSCIENCE INC (LPDX)

Related News

No related news articles were found.

liposcience inc (LPDX) Related Businessweek News

No Related Businessweek News Found

liposcience inc (LPDX) Details

LipoScience, Inc., a clinical diagnostic company, is engaged in the field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology in the United States. The company’s technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and small molecule metabolites. It offers NMR LipoProfile test, which directly measures various low density lipoprotein (LDL) particles in a blood sample, and provides physicians and their patients with information to personalize management of risk for heart disease. LipoScience, Inc. sells its NMR LipoProfile test to clinical diagnostic laboratories, clinicians, and other healthcare professionals for use in patient care. The company was formerly known as LipoMed, Inc. and changed its name to LipoScience, Inc. in January 2002. LipoScience, Inc. was incorporated in 1994 and is headquartered in Raleigh, North Carolina.

239 Employees
Last Reported Date: 03/28/14
Founded in 1994

liposcience inc (LPDX) Top Compensated Officers

Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $318.0K
Compensation as of Fiscal Year 2013.

liposcience inc (LPDX) Key Developments

LipoScience, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

LipoScience, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenues of $12,008,000 against $13,616,000 a year ago. Loss from operations was $1,613,000 against $2,332,000 a year ago. Net loss was $2,043,000 or $0.13 per basic and diluted share against $2,848,000 or $0.19 per basic and diluted share a year ago. Net cash used in operating activities was $2,762,000 against $5,764,000 a year ago. Purchases of property and equipment were $1,833,000 against $1,221,000 a year ago.

LipoScience, Inc. Announces Plans to Reduce Workforce; Announces Resignation of Timothy J. Fischer as Chief Operating Officer, Effective May 1, 2014

In a proactive effort to manage its cash, LipoScience, Inc. announced a reduction in workforce. This announcement represents the latest step in the company's efforts to streamline its operations and further manage its operating costs. The action, taken in response to the company's March 28, 2014 decision to terminate its contract with Health Diagnostic Laboratory, resulted in a reduction of approximately 22 positions or approximately 10% of the workforce across the company. The company anticipates that it will complete the implementation of the plan during the second quarter of 2014. The company estimates that it will incur total expenses relating to termination benefits of approximately $1,000,000, all of which represent cash expenditures. In connection with the reduction in force, Timothy J. Fischer, chief operating officer of the company, is separating from the company effective May 1, 2014.

LipoScience, Inc., Q1 2014 Earnings Call, May 12, 2014

LipoScience, Inc., Q1 2014 Earnings Call, May 12, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPDX:US $3.31 USD -0.08

LPDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BG Medicine Inc $0.97 USD -0.0041
Bio-Reference Labs Inc $30.40 USD -0.54
Genomic Health Inc $26.70 USD +0.54
MDxHealth €3.34 EUR -0.036
QIAGEN NV €18.05 EUR +0.209
View Industry Companies

Industry Analysis


Industry Average

Valuation LPDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIPOSCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at